FIELD: biotechnology.
SUBSTANCE: group of inventions relates to biotechnology, specifically to the use of Lys-C and a method for proteolytic processing of single-stranded botulinum neurotoxin serotype A (BoNT/A) to form an active, double-stranded botulinum neurotoxin serotype A (BoNT/A). Lys-C hydrolyses a single-stranded botulinum neurotoxin serotype A (BoNT/A) to form an active double-stranded botulinum neurotoxin serotype A (BoNT/A).
EFFECT: invention makes it possible to obtain active double-stranded BoNT/A without undesirable secondary cleavage products.
9 cl, 11 dwg, 8 ex, 2 tbl
Authors
Dates
2018-12-03—Published
2012-11-21—Filed